Your search results.

Pages

  1. Boehringer Ingelheim Vetmedica, Inc., Launches ULTRA™ Fel-O-Vax®,the First and Only ½ mL Vaccine Line for Cats

    About Boehringer Ingelheim

    The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

    • Size: 36.87 kB
    • Last Update: 27.04.2016
  2. Area Regional Control, Bioportal data help in swine disease management

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 36.83 kB
    • Last Update: 18.04.2016
  3. Swine Vets, Researchers Encouraged to Submit Proposals for BIVI PRRS Research Awards

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 36.87 kB
    • Last Update: 19.04.2016
  4. 20 Years of Innovations Yield Big Gains in PRRS Control in Pigs Today

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 36.97 kB
    • Last Update: 22.04.2016
  5. Boehringer Ingelheim Vetmedica, Inc., a Market-Leading Manufacturer of Animal Vaccines, Celebrates Opening of New, Global Packaging and Distribution Warehouse in KC Animal Health Corridor

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 36.14 kB
    • Last Update: 18.04.2016
  6. BIVI Announces Prascend® Horse Owner Contest Winners

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 37.78 kB
    • Last Update: 18.04.2016
  7. BIVI Recognizes Employees at Local Celebration for State Award

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 34.38 kB
    • Last Update: 22.04.2016
  8. BIVI Announces The 2014 Equine Research Award Recipients

    BIVI Announces The 2014 Equine Research Award Recipients

    • Size: 32.11 kB
    • Last Update: 19.04.2016
  9. Boehringer Ingelheim Vetmedica, Inc. (BIVI) announces major capital investment in its facilities in Fort Dodge and Ames

    Boehringer Ingelheim Vetmedica, Inc. (BIVI) announces major capital investment in its facilities in Fort Dodge and Ames

    • Size: 34.98 kB
    • Last Update: 28.03.2016
  10. Boehringer Ingelheim Vetmedica, Inc. Receives Pregnant Mare Label Claim for Vetera® Vaccines

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 35.32 kB
    • Last Update: 20.04.2016

Pages